Bicara Therapeutics Inc. (BCAX) stock
BCAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$9.38−0.22 (-2.29%)
Close on Nov 18, 2026Market cap $620.70MP/E –Yield –
Bicara Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Bicara Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 2.5× a year earlier. Over the last 2 years it ranged from 1.1× to 3.8×, with a median of 2.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.5× | −0.8 |
| 2025 | Dec 31, 2025 | 2.3× | +0.4 |
| 2024 | Dec 31, 2024 | 1.9× | – |
See a number that looks wrong?